Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Off-Label Promotion Cases Need Better Oversight In Justice Dept., WLF Says

Executive Summary

Responsibility for coordination of federal off-label promotion investigations should be transferred to the Department of Justice Criminal Division to help ensure appropriate protection of First Amendment rights, the Washington Legal Foundation said in a recent petition to DoJ

You may also be interested in...



Good Reprint Practices: FDA’s Draft Guidance Aims For Middle Ground

A newly released FDA draft guidance detailing a roadmap for acceptable dissemination of information on off-label drug use implies that companies need to garner enough data for a new drug application before distributing content

Good Reprint Practices: FDA’s Draft Guidance Aims For Middle Ground

A newly released FDA draft guidance detailing a roadmap for acceptable dissemination of information on off-label drug use implies that companies need to garner enough data for a new drug application before distributing content

Pharma Should Enlist Patients, Physicians To Fight Off-Label Litigation

Drug makers should partner with patient advocacy groups and physicians to fight a growing pattern of litigation related to the dissemination of off-label drug information, Sidley Austin Brown & Wood Partner Paul Kalb said during a Drug Information Association workshop Feb. 22 in New York

Related Content

Topics

UsernamePublicRestriction

Register

PS142351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel